Loss of the Endothelial Glucocorticoid Receptor Prevents the Therapeutic Protection Afforded by Dexamethasone after LPS

Open Access

Peer-reviewed

Research Article

Julie E. Goodwin ,

* E-mail: julie.goodwin@yale.edu

Affiliation Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯
Yan Feng,

Affiliation Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯
Heino Velazquez,

Affiliation Department of Internal Medicine, Veterans Affairs Hospital, West Haven, Connecticut, United States of America
⨯
Han Zhou,

Affiliation Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯
William C. Sessa

Affiliations Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, Connecticut, United States of America, Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯

Reader Comments (0)

Transcription factors
Is the Subject Area "Transcription factors" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Inflammation
Is the Subject Area "Inflammation" applicable to this article?

Thanks for your feedback.
Macrophages
Is the Subject Area "Macrophages" applicable to this article?

Thanks for your feedback.
Sepsis
Is the Subject Area "Sepsis" applicable to this article?

Thanks for your feedback.
Glucocorticoid therapy
Is the Subject Area "Glucocorticoid therapy" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Endothelial cells
Is the Subject Area "Endothelial cells" applicable to this article?

Thanks for your feedback.